Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 11;9(4):ofac071.
doi: 10.1093/ofid/ofac071. eCollection 2022 Apr.

A Review of Hemophagocytic Lymphohistiocytosis in Patients With HIV

Hussam Tabaja  1 , Amjad Kanj  2 , Said El Zein  1 , Isin Yagmur Comba  1 , Omar Chehab  3 , Maryam Mahmood  1
Affiliations
Review

A Review of Hemophagocytic Lymphohistiocytosis in Patients With HIV

Hussam Tabaja et al. Open Forum Infect Dis. .

Abstract

We provide an elaborate review of cases published between January 2005 and April 2021 on hemophagocytic lymphohistiocytosis (HLH) in HIV patients. Seventy articles describing 81 adult patients (age ≥19 years) were included. The median age was 40 years, and 78% were males. Only 65% were known to have HIV before presentation. CD4 count was ≥200 cells/mm3 in 23%, and HIV viral load was <200 copies/mL in 41%. The lack of meticulous reporting of ≥5 of 8 criteria for HLH diagnosis was evident in a third of cases. At least 1 infectious agent-other than HIV-was believed to trigger HLH in 78% of patients. The most common were Epstein-Barr virus (26%), human herpesvirus 8 (21%), and Histoplasma capsulatum (17%). Sixty percent survived. Among those, 93% received treatment for identified secondary trigger(s), while 51% received HLH-directed therapy. There was significant heterogeneity in the treatment regimens used for HLH.

Keywords: AIDS; HIV; hemophagocytosis; lymphohistiocytosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram of literature review methodology used to identify all PubMed indexed cases of HLH in HIV patients reported from January 2005 until April 2021. Abbreviation: HLH, hemophagocytic lymphohistiocytosis.
See this image and copyright information in PMC

References

    1. Henter JI, Horne A, Arico M, et al. . HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:124–31. - PubMed
    1. Thomas W, Veer MV, Besser M.. Haemophagocytic lymphohistiocytosis: an elusive syndrome. Clin Med (Lond) 2016; 16:432–6. - PMC - PubMed
    1. Yoon JH, Park SS, Jeon YW, et al. . Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica 2019; 104:269–76. - PMC - PubMed
    1. Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol 1992; 9:63–74. - PubMed
    1. Janka GE, Lehmberg K.. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 2013; 2013:605–11. - PubMed